News
In the aftermath of several deals with smaller biotechs made in the 13 months in the cardiometabolic space, Novo Nordisk has ...
US chemical output slows, National Resilience consolidates operations, AstraZeneca partners with a Chinese firm, and more ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback